Peijia Medical Executive and Leadership Team

Michael Zhang, the Chairman & Chief Executive Officer at Peijia Medical, directs the overarching corporate strategy for structural heart and neurovascular intervention markets. Overseeing long-term growth initiatives, the Chairman & Chief Executive Officer aligns research priorities with global clinical needs. This leadership role involves managing board relations and securing capital for high-end medical device development. By fostering partnerships with international healthcare providers, Michael Zhang ensures the company maintains a competitive edge in complex cardiovascular markets. The Chairman & Chief Executive Officer monitors the efficacy of aortic and mitral valve product lines to guarantee safety and accessibility. Through rigorous oversight of corporate governance, the Chairman & Chief Executive Officer drives the expansion of the company footprint across diverse medical sectors. Ultimately, the Chairman & Chief Executive Officer secures the future of the organization by prioritizing innovation and patient-centric solutions in every strategic decision.

Leo Tsai, the Chief Financial Officer at Peijia Medical, manages the fiscal health and capital allocation strategies required for high-end medical device manufacturing. Overseeing financial reporting and investor relations, the Chief Financial Officer ensures transparency and stability for stakeholders. This leadership role involves optimizing the budget for neurovascular intervention research and development. By analyzing market trends in the structural heart disease sector, Leo Tsai directs the financial planning necessary for sustainable growth. The Chief Financial Officer coordinates with the board to evaluate investment opportunities in surgical accessories and advanced valve technologies. Through disciplined cost management and revenue forecasting, the Chief Financial Officer supports the operational scale of the company across international markets. Ultimately, the Chief Financial Officer maintains the financial integrity of the organization, providing the necessary resources to advance medical solutions that improve patient quality of life.

Karl Pan, the Chief Operating Officer at Peijia Medical, executes the daily operational strategies required to manufacture and distribute high-end medical devices. Overseeing supply chain logistics and production efficiency, the Chief Operating Officer ensures the seamless delivery of structural heart and neurovascular intervention products. This leadership role involves streamlining internal processes to meet the rigorous demands of global healthcare providers. By managing cross-functional teams, Karl Pan optimizes the manufacturing workflow for aortic and mitral valves. The Chief Operating Officer monitors quality control standards to maintain compliance with international medical regulations. Through the coordination of regional distribution networks, the Chief Operating Officer supports the company expansion into diverse markets. Ultimately, the Chief Operating Officer drives operational excellence, ensuring that the organization consistently provides accessible and effective medical solutions to improve patient quality of life across the globe.

JianFong Tan, the Chief Technology Officer at Peijia Medical, architects the technical roadmap for innovative structural heart and neurovascular intervention products. Overseeing the engineering teams, the Chief Technology Officer drives the development of next-generation aortic, mitral, and tricuspid valves. This leadership role involves translating complex clinical requirements into safe, effective medical devices. By spearheading research into advanced materials and surgical accessories, JianFong Tan ensures the company remains at the forefront of medical technology. The Chief Technology Officer collaborates with clinical experts to refine product design and performance standards. Through the implementation of cutting-edge manufacturing processes, the Chief Technology Officer enhances the reliability of the entire product portfolio. Ultimately, the Chief Technology Officer accelerates the delivery of life-saving solutions to hospitals and healthcare providers, ensuring that every technological advancement directly contributes to superior patient outcomes and improved quality of life.